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An acute myocardial infarction (AMI) affects nearly 8 million individuals annually worldwide and is commonly caused by thrombotic occlusion of a coronary artery leading to myocardial ischemia, cardiomyocyte necrosis and infarction within minutes of onset [1] [2] . Beginning with the 'open artery theory' in the 1970's, the field of AMI management has been dominated by the principle that 'time is muscle', recognizing that prolonged coronary occlusion leads to ongoing myocardial injury [3] [4] . For this reason, the well-established paradigm of contemporary management of AMI focuses on rapid coronary reperfusion via balloon angioplasty and stenting to limit myocardial injury. The metric for success in AMI therapy is a Door to Balloon time (DTB) less than 90 minutes, which is defined as the interval from patient arrival in the emergency department to mechanical reperfusion of the occluded coronary artery. The DTB time is a standard part of ACC/AHA guidelines and a core quality measure of hospital performance 5 .
However, despite timely reperfusion, nearly 10% of AMI subjects die during their index hospitalization and 25% of survivors progress to develop chronic heart failure 6 . One explanation for these poor outcomes is that reperfusion of ischemic myocardium can also cause cardiomyocyte death and microvascular damage through a process referred to as myocardial ischemia-reperfusion injury (IRI) 6, 7 . These data suggest that despite progress in the treatment of AMI, a major scientific problem is the need for novel approaches to limit myocardial damage due to reperfusion injury.
Pharmacologic approaches to limit reperfusion injury have focused on attenuating mitochondrial permeability transition pore (mPTP) generation and promoting activity of rapidly inducible salvage kinases (RISK), including extracellular regulated kinase (ERK) and the serine/threonine kinase, Akt [8] [9] [10] [11] [12] . Other approaches to limit IRI include systemic hypothermia which has also shown promise as a method to reduce total body metabolic demand 13 , however emergency department to mechanical reperfusion of the occluded coronary arter ry y y. T T The he e D D DTB TB TB t ti ime s a standard part of ACC/AHA guidelines and a core quality measure of hospital performance 5 .
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While promising, critical barriers to these cardioprotective strategies include: 1) the multifactorial nature of reperfusion injury, thereby limiting the impact of a single-target pharmacologic strategy, 2) the potential for coronary vascular injury (dissection or perforation)
with IC, and 3) the mandate for rapid coronary reperfusion and therefore insufficient time for a drug to penetrate into myocardial injury zones. There exists a need for improved cardioprotective strategies that broadly impact the multiple levels of reperfusion injury without causing further myocardial damage. In this study, we explore the central hypothesis that initially reducing LV wall stress by mechanically reducing LV preload, while delaying coronary reperfusion activates endogenous anti-IRI signaling pathways and limits myocardial injury in the setting of AMI.
Methods
Studies were conducted in 15 adult, male Yorkshire swine weighing 45+4 kg. The study protocol was approved by the Institutional Animal Care and Use Committee (IACUC) at Tufts Medical
Center. All experiments were performed according to the committee's guidelines.
Experimental Protocol of Myocardial Infarction and Mechanical Circulatory Support
Animals were premedicated with Telazol (0.8ml/kg, intramuscular). General anesthesia was induced and maintained with isoflurane (1-2%). All animals were intubated and mechanically ventilated (Harvard Apparatus Inc) with room air and supplemented oxygen to maintain physiologic pH and oxygen saturation. Surface electrocardiography leads, an orogastric tube, peripheral 18 G venous catheters, and a rectal thermistor were placed in all animals. Heating myocardial damage. In this study, we explore the central hypothesis that initially y re edu du duci ci cing ng ng L L LV V wall stress by mechanically reducing LV preload, while delaying coronary reperfusion activates en ndo do doge ge geno nous us us a a anti-i--IR IR IRI I signaling pathways and lim m mit it i s myocardial in nju ju j ry y i i in n n t the setting of AMI.
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Studies were e c c con on o du du duct ct c ed ed ed in n 15 15 15 a adu du dult lt, , ma ma ale le le Y Y Yor or orks ks kshi hi h re re r s swi wi ine ne ne w w wei ei igh gh ghin n ng g g 45 45 45+ + +4 4 4 kg kg k . . Th Th The e e st st stud u u y protoco o o pads were used as needed to maintain a core body temperature >99 o F. Vascular access sheaths were then deployed into the right internal jugular vein (10Fr), left carotid artery (7Fr), and both femoral arteries (7 Fr) HealthCare; Westerly, RI). Animals were then euthanized with pentobarbital and phenytoin after 120 minutes of reperfusion ( Figure 1A) .
To explore the impact of ischemia-reperfusion injury in a clinically relevant model of AMI, 12 adult, male swine were subjected to 120 minutes of mid-LAD occlusion and 3 animals served as sham controls. Of the 12 animals in which MI was induced, 4 animals died within 60 minutes (40; 20; 30; 60 minutes) of LAD occlusion due to refractory ventricular fibrillation. The surviving 8 animals were randomly assigned to either the MI-alone group (n=4), or the MI+Unload group (n=4) (defined below). In the MI group, 120 minutes of LAD occlusion was directly followed by 120 minutes of reperfusion without mechanical support, at which time the animals were euthanized and LV samples obtained. In the mechanically supported group angiographic confirmation of LAD occlusion. Coronary angiography also perfor rme me med d mmediately after reperfusion and again after the end of the study protocol confirmed patency of f h he e LA LA LAD. D D. L L Len en ngt th h h o of of the LAD distal to the stente e ed d d se egment was me me easur ur red ed ed in the antero-posterior proj j jec e tion off fli lin ne e u u usi si in n ng E E Enc nc ncom om ompa pass ss s ® ® ® qu qu uanti ti ita a ative e e a a angio io iogr gra a aphy hy h s s sof ftw twar ar re (H H Hea ea eart rtla lab, b, b I I Inc nc c., A A Agf gf gfa a
He He eal al a th th thCa Ca C re re e; ; ; W We Wes s ste er erly ly y, , R RI RI). ) A A Ani ni ima ma mals ls ls w w wer er re e e th th then n n e eu u uth than aniz iz i ed ed ed w w wit it th h h p pe pent nt ntob ob obar arbi bi b t ta al al a a and nd p p ph h hen n nyt to toin in af ft fter e (MI+Unload), we employed a centrifugal flow pump (TandemHeart; Cardiac Assist Inc), as described below, which is utilized currently in clinical practice as a percutaneous left atrial-tofemoral artery (pLA-FA) support system [17] [18] [19] . In the MI+Unload group, the centrifugal flow pump was deployed and clamped until the completion of 120 minutes of LAD occlusion at which time the pump was activated. A flow-probe attached to the outflow cannula directly measured device flow. Coronary reperfusion was then delayed for an additional 30 minutes in this group. After reperfusion, the mechanical pump remained active throughout the 120 minutes of reperfusion, followed by euthanasia and tissue harvesting as in the MI group ( Figure 1A) . To deploy the pLA-FA support system, trans-septal puncture of the inter-atrial septum was performed using a Brockenbrough needle and a trans-septal dilator (Boston Scientific) via the right femoral vein. An Inoue wire was deployed into the left atrium and a staged 14-to-21Fr dilator used to place a 21Fr inflow cannula into the left atrium ( Figures 1B and 1C) . Next, a 15Fr arterial cannula was placed into the left femoral artery. Both cannulas were then connected to a de-aired centrifugal flow pump and clamped ( Figure 1B) . Finally, 3 sham-operated animals were intubated, anesthetized, and mechanically ventilated without myocardial infarction or mechanical unloading. LV tissue samples obtained from sham controls were used for western blot analysis.
Conductance Catheter Assessment of LV Pressure and Volume
Changes in LV pressure and volume were assessed using a 5Fr-conductance catheter system (Sigma-M; CD Leycom, The Netherlands) deployed via the left carotid into the LV ( Figure 1C) .
Ventricular pressure and volume were measured at baseline, after 120 minutes of LAD occlusion, and after 120 minutes of reperfusion using a solid-state pressure transducer and dualfield excitation mode respectively as previously described 20, 21 . Briefly, the method measures performed using a Brockenbrough needle and a trans-septal dilator (Boston Scien en nti ifi fi f c) c) ) v via ia ia t t the h he ight femoral vein. An Inoue wire was deployed into the left atrium and a staged 14-to-21Fr di ila la ato to tor r r us used ed ed t to o pl pl lac ac ace e a 21Fr inflow cannula into th th the e left atrium (Fi Fi igu g re re es s s 1 1B and 1C d ). Next, a 1 15 5F Fr Fr arterial ca can nn nu u ula a wa wa was s p pl plac ac aced ed i i int nt nto o t th he e e lef ft ft f f femor or ora al a a art rt ter ery y y. Bo Bot th th can annu n nula las s we w were re t t the he hen n co co c n nn nnec e ect te ted 20, 21 . Parallel conductance was assessed by injecting 20mL of hypertonic (6%) saline into the right internal jugular vein 22 . Absolute LV volumes were measured by subtracting parallel conductance from total conductance volumes and further confirmed by direct volumetric measurements using 3D-echocardiography as described below. Stroke volume is calculated as the difference in conductance volumes at +dP/dtmax and -dP/dtmin. An estimated end-systolic pressure volume relationship (ESPVR) was calculated as peak LV end-systolic pressure divided by stroke volume for a single cardiac cycle. LV stroke work was calculated as the product of peak LV peak systolic pressure and stroke volume.
Three-Dimensional Echocardiography
To evaluate LV myocardial mechanics, three-dimensional speckle tracking echocardiography (3D-STE) was performed using the Artida 4D System (Toshiba Medical Systems, Tustin, California) and matrix array PST-25SX transducer. For optimal imaging, all animals underwent a 4cm mid-line abdominal incision for sub-diaphragmatic placement of the transducer in proximity to the LV apex. Three-dimensional data sets consisted of apical full volumes created by the combination of 6 ECG-gated, wedge-shaped sub-volumes during a single breath hold. Along with the combination of 6 sub-volumes, both optimization of 3D images and adjustments in depth and full volume sector angles yielded a temporal resolution of 20 to 30 volumes per second. Off-line processing for speckle tracking analysis was performed through the Wall Motion Tracking software (Toshiba Medical Systems) as previously described [23] [24] [25] . Longitudinal pressure volume relationship (ESPVR) was calculated as peak LV end-systolic p pr r ress s s u ur re e di di divi vi vid de ded by stroke volume for a single cardiac cycle. LV stroke work was calculated as the product of pe eak ak ak L L LV V V pe pe peak ak ak sys ys yst to tolic pressure and stroke volum me me.
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To To e e eva va valu luat ate e e LV L LV m m my yo yoc ca ard rd dia ial m me mech ch chan an anic ics s, s, t t thr hr hre e ee--di di dim m men n nsio io ona na nal l l sp sp s ec ec eck kl kle e tr tr trac ac cki ki ing ng n e e ech ch choc oc car ar ard dio o ogr ra raph ph hy 3D-STE) w was as s p p per er rfo fo form rm med e e u u usi si ing ng ng t t the he h A A Art rt tid id ida a a 4D 4D 4D Sy Sy Syst st tem em em ( (To To Tosh sh shib ib ba a a Me Me Medi di dica ca cal l Sy Sy Syst stem em ems, s, s, T T Tus us u tin, and circumferential LV strain with 3D-STE was quantified as myocardial deformation, defined as the percent change in length between pairs of points throughout the cardiac cycle relative to the initial length in longitudinal and circumferential directions, respectively, relative to the endocardial contour. 3D-STE derived global values for longitudinal and circumferential strain were obtained from the rendered 16-segment model with exclusion of the apical-most segment due to imaging dropout. Left ventricular peak wall stress (LVPWS), mean wall stress (LVMWS), and systolic wall tension (LVSWT) were also calculated as previously described [26] [27] [28] .
Determination of Myocardial Infarct Size
Upon completion of the study protocol, animals were euthanized and hearts immediately excised and manually flushed with normal saline. Both atria and the right ventricle were removed and the LV cross-sectioned into 1 cm segments perpendicular to the long axis. Coronary stents were visualized to confirm location of the mid-LAD occlusion segment. Biopsy specimens were obtained from the anterio-apical LV distal to the site of stent deployment (infarct zone) and from the postero-basal wall (non-infarct zone) for molecular analysis and LV slices then incubated in 1% triphenyltetrazolium chloride (TTC) at 37°C for 5 minutes for non-infarct staining. LV slices were then photographed and digitized planimetry was used to quantify infarct zones expressed as a percentage of total myocardium. Blood samples obtained during the study protocol were centrifuged at 5000 rotations per minute for 15 minutes for isolation of serum and plasma, which
were then stored at -80°C. Cardiac biomarkers (CK-Mb and Troponin-I) were measured by Anilytics (Gaithersburg, MD).
Immunoblot Analysis (Western)
Total protein was extracted from tissue homogenates isolated as previously described (Ref 14) .
Immunoblot analysis was then performed as previously described 29, 30 using antibodies against and manually flushed with normal saline. Both atria and the right ventricle were e r r rem m mov ov ved ed ed a a and nd nd the LV cross-sectioned into 1 cm segments perpendicular to the long axis. Coronary stents were vi isu su ual al aliz iz ized ed ed t t to o c conf nf nfi ir irm m location of the mid-LAD oc oc occl lusion segmen nt. t. t Bio io ops ps psy y specimens were ob bta a ain i ed from m th th the an ante te eri io o-o-ap ap apic ic ical al L L LV V V d di ist t tal to o o t t the s s sit te o of f s ste tent nt n d de ep p plo oy oyme me en nt t ( (in in nfa fa farc rct t t zo zo zone ne) ) a an and d d fr r ro om h he e e po po post st s er ero-o-o-ba ba b sa sal l w wa wall ll (n no non n-in in infa fa farc rc rct t t z zo zon ne ne) ) ) fo fo for r r mo mo mole le ecu cu ula a ar r an an anal a alys ys sis is i a and nd nd L LV V V sl slic ic ces es e t the he en n n i inc c cub ba bate te ed d in in i 1% triphenyl ylte te tetr tr raz az zol ol oliu iu um m m ch h hlo lo lori r r de de de ( (TT TT TTC) C) C) a a at t t 37 37 37°C C C f fo o or r r 5 5 mi mi minu nu nute te tes s s fo fo for no no non-n-n in in infa fa farc rc r t t st st tai ai aini ni n ng ng ng. LV slices s porcine total ERK, phosphorylated ERK-1/2 (pERK-1/2), Total AKT, phosphorylated Akt (pAKT), and GAPDH. Expression of pERK-1/2 and pAKTwere normalized to both total protein levels and GAPDH.
Statistical Analysis
Results are presented as mean+SD. All data within groups were analyzed by non-parametric twoway repeated measures ANOVA on ranks followed by a Holm-Sidak comparison if warranted.
Simple linear regression analysis was used to evaluate for a correlation between two parameters.
Given the small sample size (n=4/group), any p-values throughout the manuscript from comparing the randomized groups are unreliable, and should be interpreted with caution. All statistical analyses were performed with SigmaStat version 3.1 (Systat Software, Inc). An -level of p<0.05 was considered to indicate a significant effect or between-group difference.
Results

Mechanical Unloading in AMI Promotes Hemodynamic Stability and Reduces LV Wall Stress
The hemodynamic effects of ischemia and reperfusion injury with and without mechanical unloading are shown in Figure 2) . Given the small sample size (n=4/group), any p-values throughout the manuscript from comparing the randomized groups are unreliable, and should be interpreted with caution.
These findings support that despite identical degrees of hemodynamic compromise due to LAD occlusion, pLA-FA bypass in the MI+Unload group reduced LV wall stress and stroke work, while supporting MAP.
Reperfusion Impairs Myocardial Strain
We next examined the functional impact of ischemia-reperfusion injury in AMI on LV volumes and strain using 3D-STE. In both the MI and MI+Unload groups, 120 minutes of LAD occlusion did not significantly change LV end-systolic and end-diastolic volumes (LVESV and LVEDV) from baseline. In the MI group, after 120 minutes of reperfusion, LVESV and LVEDV remained unchanged. In contrast, compared to baseline values, LVEDV was significantly reduced after 120 minutes of reperfusion in the MI+Unload group ( Table 1 and Supplemental Figure 1 ).
Both LVESV and LVEDV were lower in the MI+Unload group compared to MI alone. We next examined changes in circumferential and longitudinal LV strain. In both groups, 120 minutes of LAD occlusion did not significantly change either circumferential ( Figure 3A-B 
Mechanical Unloading Promotes Reperfusion Injury Salvage Kinase (RISK) Pathway Activity
To begin exploring whether mechanical unloading promotes myocardial salvage in AMI, we quantified RISK pathway activation. Compared to sham controls, LV tissue from the non-infarct zone showed no change in pERK and pAkt expression in the MI group. However, compared to sham controls or the MI group, pERK and pAkt expression was increased in LV samples from the non-infarct zone in the MI+Unload (Figure 4) . Compared to sham controls, levels of pERK and pAkt were not significantly changed in the infarct zone from both groups (data not shown).
These findings suggest that mechanical unloading prior to reperfusion activates signaling pathways that protect against reperfusion injury in the non-infarct zone during AMI.
Mechanically Reducing LV wall stress and Delaying Coronary Reperfusion Reduces
Myocardial Infarct Size
We next explored whether mechanically reducing LV wall stress and stroke work while delaying coronary reperfusion impacts myocardial infarct size. To account for regional perfusion of the LAD, no differences in LAD length (80+3 vs 78+3 mm, MI vs MI+Unload, p=0.4) or LV mass
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Discussion
Our central finding is that mechanically unloading the LV, despite delaying coronary reperfusion, reduces LV wall stress and activates signaling pathways that promote myocardial salvage, leading to significantly reduced myocardial injury in a preclinical model of acute myocardial infarction. Specifically we report that: 1) reducing LV preload with a percutaneously delivered left atrial to femoral artery circuit driven by a centrifugal pump significantly reduces LV volume, pressure, and native stroke volume, which in turn reduces LV wall stress, stroke work, and circumferential strain in AMI, while maintaining mean arterial pressure, 2) LV unloading and delaying reperfusion during an AMI promotes phosphorylation of proteins involved in the RISK pathway, and 3) this approach significantly limits myocardial damage as measured by TTC staining and cardiac biomarker release. These findings suggest that initially 
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The clinical implications of these findings will require further study.
Over the past 4 decades, acute circulatory support devices have evolved from large, pulsatile systems to miniaturized, percutaneously-delivered pumps 31 . These pumps, which include the intra-aortic balloon pump (IABP) From the moment a coronary artery becomes occluded a proverbial clock begins to count minutes that are directly associated with ongoing myocardial cell injury and death. Using this model, we show that mechanically reducing LV preload using a pLA-FA bypass mechanism significantly reduces both LV wall stress and stroke work after reperfusion without the need to directly cannulate the LV. We further show that device activation reduces circumferential LV strain after 120 minutes of reperfusion in AMI and that circumferential global strain correlates directly with quantified LV wall stress and stroke work. These data indicate a potentially important role for circulatory support devices that target preload as a method to unload the LV.
Furthermore, previous studies have shown that reduced LV wall stress and stroke work correlate with reduced myocardial oxygen consumption 38, 39 . Our data suggest that reducing LV wall stress, stroke work, and strain may promote myocardial salvage in AMI by reducing myocardial pressures and biventricular function and allows us to more accurately study the he he hemo m m dy dy dyna na nami mi mic c effect of percutaneously delivered mechanical support and further makes the model clinically e ele le eva va vant nt nt t t to o o co co contem em mp porary interventional approac c ch he hes s s to AMI thera apy p p .
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By initiating mechanical support first and sustaining systemic perfusion while reducing native LV work, we have created a window in time where the process of myocardial injury is slowed and delaying coronary reperfusion is now possible while incurring only minimal additional ischemic damage. By delaying reperfusion in the setting of mechanically reduced oxygen demand, time is now available for activation of signaling pathways known to promote myocardial salvage including phosphorylation of ERK and Akt. These findings suggest that the milieu for reperfusion injury may be modified such that coronary revascularization may ultimately be accomplished without triggering significant reperfusion injury. This approach also opens the possibility for implementation of other adjunctive cardioprotective strategies including systemic drug administration, intra-coronary drug delivery into an injured segment, more aggressive mechanical ischemic post-conditioning, or remote ischemic conditioning. The combination of mechanical support, adjunct cardioprotective therapy, and delayed reperfusion may ultimately lead to optimal myocardial salvage in AMI. While, the contemporary strategy of treating AMI is dominated by a quest to achieve rapid coronary recanalization in AMI (Door to Balloon Time), we now propose that first mechanically reducing LV preload (Door to Unload) and then delaying coronary reperfusion will promote RISK pathway activation and significantly reduce myocardial infarct size. Further study is required to establish whether this theoretical benefit of early and maximal LV unloading is a clinically viable strategy in AMI.
Limitations of the presents study include the technical limitation of measuring myocardial oxygen consumption, coronary collateral flow, and total aortic flow due to multiple intra-cardiac catheters and large-bore cannulas in the vena cava. Furthermore, the number of animals studied is small due in part to a 33% mortality rate among animals subjected to opens the possibility for implementation of other adjunctive cardioprotective stra ra ate tegi gi g e es s i inc nc nclu lu lud di ding g d 
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